| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 119630-94-3 | Naloxone benzoylhydrazone | C26H27N3O4 |
| 119637-67-1 | Moguisteine | C16H21NO5S |
| 119642-82-9 | Yucalexin P 17 | C20H30O3 |
| 119644-22-3 | 2',3'-Dideoxy-3'-fluoro-5-chlorouridine | C9H10ClFN2O4 |
| 119644-23-4 | 2',3'-Dideoxy-3'-fluoro-5-iodouridine | C9H10FIN2O4 |
| 119665-62-2 | 6-O-Methyl-2',4''-bis-O-(trimethylsilyl)erythromycin 9-[O-(1-ethoxy-1-methylethyl)oxime] | C49H96N2O14Si2 |
| 119673-08-4 | Becatecarin | C33H34Cl2N4O7 |
| 119677-21-3 | trans-3-Hydroxy-D-proline | C5H9NO3 |
| 119692-59-0 | 4-(Oxiran-2-ylmethoxy)butyl acrylate | C10H16O4 |
| 119699-81-9 | 6-O-Methyl-2',4'-bis-O-(trimethylsilyl)erythromycin 9-[O-(1-methoxy-1-methylethyl)oxime] | C48H94N2O14Si2 |
| 119707-74-3 | (S)-3,3'-Dibromo-1,1'-binaphthalene-2,2'-diol | C20H12Br2O2 |
| 119717-21-4 | Levomedetomidine | C13H16N2 |
| 119725-19-8 | 2-Epitormentic acid | C30H48O5 |
| 119725-20-1 | Fupenzic acid | C30H44O5 |
| 119730-89-1 | Baohuoside VII | C33H40O15 |
| 119736-16-2 | 3-Benzyloxy-4-oxo-4H-pyran-2-carboxylic acid | C13H10O5 |
| 119736-19-5 | 5-Benzyloxy-1-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid | C14H13NO4 |
| 119736-51-5 | 3-Indolyl-beta-D-glucuronic acid sodium salt | C14H14NNaO7 |
| 119738-06-6 | Quizalofop-p-tefuryl | C22H21ClN2O5 |
| 119738-57-7 | Clerodendrin (glycoside) | C27H26O17 |
| 119752-83-9 | 1,4-disulfino-1,4-Diazoniabicyclo[2.2.2]octane bis(inner salt) | C6H12N2O4S2 |
| 119767-00-9 | 1H-Pyrrole-2-carboxylic acid 3-furanylmethyl ester | C10H9NO3 |
| 119767-84-9 | [(1S,2R)-2-(tert-Butoxy)-1-[[(4-oxo-1,2,3-benzotriazin-3(4H)-yl)oxy]carbonyl]propyl]carbamic acid 9H-fluoren-9-ylmethyl ester | C30H30N4O6 |
| 119770-60-4 | (1-Methyl-4-piperidinyl)[3-[2-(3-chlorophenyl)ethyl]pyridinyl]methanone hydrochloride | C20H23ClN2O.HCl |
| 119771-23-2 | N-(tert-Butoxycarbonyl)-4-(dihydroxyboryl)-L-phenylalanine | C14H20BNO6 |
| 119791-41-2 / 123997-28-4 | Emamectin | |
| 119793-66-7 | Propionyl-L-carnitine hydrochloride | C10H20ClNO4 |
| 119794-51-3 | N-Acetyl-5'-O-[(1,1-dimethylethyl)dimethylsilyl]cytidine | C17H29N3O6Si |
| 119802-68-5 | 3-Chloro-alpha-[1-[(1,1-dimethylethyl)amino]ethyl]benzenemethanol | C13H20ClNO |
| 119803-27-9 | N-[1-[5-O-[Bis(4-methoxyphenyl)phenylmethyl]-2-deoxy-beta-D-erythro-pentofuranosyl]-1H-pyrazolo[3,4-d]pyrimidin-4-yl]benzamide | C38H35N5O6 |
| 119812-29-2 | 3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride | C16H20N2O.HCl |
| 119824-65-6 | N-(Phenoxyacetyl)adenosine | C18H19N5O6 |
| 119824-66-7 | N2-Phenoxyacetylguanosine | C18H19N5O7 |
| 119830-32-9 | 3-(N-Benzylamino)-L-alanine | C10H14N2O2 |
| 119831-72-0 | N5-[[[(3,4-Dihydro-2,2,5,7,8-pentamethyl-2H-1-benzopyran-6-yl)sulfonyl]amino]iminomethyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-ornithine | C35H42N4O7S |
| 119851-28-4 | 1-[2-Chloro-4-(4-chlorophenoxy)phenyl]ethan-1-one | C14H10Cl2O2 |
| 119858-52-5 | 2-Methylimidazo[1,2-a]pyridine-8-amine | C8H9N3 |
| 119878-90-9 | (R)-2-Oxo-5-phenyl-4-morpholinecarboxylic acid tert-butyl ester | C15H19NO4 |
| 119879-92-4 | N-[2-Bromo-5-(phenylmethoxy)phenyl]carbamic acid tert-butyl ester | C18H20BrNO3 |
| 119894-20-1 | O-Ethyl-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-tyrosine | C26H25NO5 |
| 119895-68-0 | 2,2-Difluorobenzodioxole-4-carboxaldehyde | C8H4F2O3 |
| 119895-95-3 | DTPA-BMA | C16H29N5O8 |
| 119904-90-4 | (S)-3-Aminoquinuclidine dihydrochloride | C7H14N2.2(HCl) |
| 119910-45-1 | 2-Bromo-1H-indole-3-carboxaldehyde | C9H6BrNO |
| 119911-68-1 | Human calcitonin gene-related peptide(8-37) | C139H230N44O38 |
| 119914-60-2 | Grepafloxacin | C19H22FN3O3 |
| 119916-22-2 | 3,4,6-Trifluoro-2-methylbenzoic acid | C8H5F3O2 |
| 119922-85-9 | Cefadroxil hemihydrate | 2(C16H17N3O5S).H2O |
| 119942-99-3 | Phosphoramidon disodium salt | C23H32N3Na2O10P |
| 119967-49-6 | 2-(3-Pyridinyloxy)ethanol | C7H9NO2 |